Growing CDMO Upperton Pharma Solutions is expanding its sterile manufacturing capacity in Nottingham and emphasizes state‑of‑the‑art aseptic processes aligned with Annex 1, signaling a readiness to take on more complex manufacturing programs and longer‑term partnerships.

Awarded Workplace Recognition as a top place to work and multiple Medilink Midlands awards in 2026 highlight a strong, stable culture and talent retention potential, making it an attractive partner for collaborative development programs and long‑term staffing support.

Clinical to Commercial End‑to‑end development capability from early feasibility to GMP/IMP manufacturing positions Upperton as a one‑stop partner for biotech and pharma companies seeking streamlined transition from development to clinical trial supply and potential commercial scale.

Specialised Tech World‑leading expertise in spray drying and comprehensive analytical support provide a differentiator for clients with challenging molecules, suggesting opportunities to target firms needing advanced formulation technologies and robust stability testing.

Global Reach, Local Scale An extensive multinational client base with recent expansion in Europe and Northern Europe creates opportunities to cross‑sell services across dose forms, regulatory support, and scalable manufacturing, particularly for sponsors seeking regional CDMO partnerships.